Citation Impact
Citing Papers
Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)
2009 Standout
Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data
1997 Standout
Carboplatin dosage: prospective evaluation of a simple formula based on renal function.
1989 Standout
The Significance of c-erb B-2 and p53 Immunoreactivity in Patients with Adenocarcinoma of the Esophagus
1995
Concurrent preoperative chemotherapy and radiation therapy in localized esophageal adenocarcinoma
1992
Preliminary results with neoadjuvant therapy and resection for esophageal carcinoma
1993
Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapy.
1990
National Cancer Data Base report on esophageal carcinoma
1996
Chemoradiotherapy of Locally Advanced Esophageal Cancer
1999 Standout
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
Soft Tissue Sarcomas
2004
The resurgence of platinum-based cancer chemotherapy
2007 Standout
Significance of Nuclear Accumulation of Foxo3a in Esophageal Squamous Cell Carcinoma
2008
High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas.
1995
Estimating the optimal utilization rates of radiotherapy for hematologic malignancies from a review of the evidence
2004
Paclitaxel (Taxol)
1995 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Immunoconjugates and long circulating systems: Origins, current state of the art and future directions
2012
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Esophageal Cancer
2003 Standout
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
1995 Standout
A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma
1996 Standout
Soft-Tissue Sarcomas in Adults
2005 Standout
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
2004 Standout
Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the Esophagus
1992 Standout
A Comparison of Multimodal Therapy and Surgery for Esophageal Adenocarcinoma
1996 Standout
Phase II Trial Of Pegylated-liposomal Doxorubicin (Doxil™) In Sarcoma*
2003
Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
1995
Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations
1994 Standout
Molecular mechanisms of cisplatin resistance
2011 Standout
Lung cancer: current therapies and new targeted treatments
2016 Standout
Impact of EUS-guided fine-needle aspiration on lymph node staging in patients with esophageal carcinoma
2001
Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study.
1997
Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials
1995
Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function
2004 StandoutNobel
Estimating the optimal utilization rates of radiotherapy for hematologic malignancies from a review of the evidence
2005
Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen.
1992
Recent advances with liposomes as pharmaceutical carriers
2005 Standout
Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung cancer: results of a North Central Cancer Treatment Group randomized clinical trial.
1994
Effect of adjuvant chemotherapy on time to recurrence and survival of stage I uterine sarcomas
1988
Cellular processing of platinum anticancer drugs
2005 Standout
Two Hundred Gastrointestinal Stromal Tumors
2000 Standout
Simultaneous versus sequential combined technique therapy for squamous cell head and neck cancer
1990
Chemoradiotherapy for localized esophageal cancer: regimen selection and molecular mechanisms of radiosensitization
2007
Oesophageal carcinoma
2013 Standout
Immunity, Inflammation, and Cancer
2010 Standout
Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma.
1996
Cardiotoxicity of Chemotherapeutic Agents
2000
Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.
1993 Standout
Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
1994
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Tumor delivery of macromolecular drugs based on the EPR effect
2010 Standout
Congestive heart failure in patients treated with doxorubicin
2003 Standout
Treatment of Relapsed/Refractory Multiple Myeloma
2009
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
Adenocarcinoma of the esophagus and esophguo-gastric junction: The effects of single and combined modalities on the survival and patterns of failure following treatment
1990
Head and Neck Cancer
1993 Standout
Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity.
1998 Standout
Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy.
1989
The biology and therapy of adult acute lymphoblastic leukemia
2003
The use of quinacrine (Atabrine) in rheumatic diseases: A reexamination
1989
A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus
1994
Randomized comparison of doxorubicin and vindesine to doxorubicin for patients with metastatic soft-tissue sarcomas
1990
Quantifying heterogeneity in a meta‐analysis
2002 Standout
Doxorubicin-Induced Cardiomyopathy
1998 Standout
Three-hour paclitaxel infusion in patients with refractory and relapsed non-Hodgkin's lymphoma.
1995
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Prognostic Factors for the Outcome of Chemotherapy in Advanced Soft Tissue Sarcoma: An Analysis of 2,185 Patients Treated With Anthracycline-Containing First-Line Regimens—A European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study
1999
Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Trial
2005 Standout
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
The Pharmacologic Basis of Ifosfamide Use in Adult Patients with Advanced Soft Tissue Sarcomas
2007
Prognostic value of pretreatment serum beta 2 microglobulin in myeloma: a Southwest Oncology Group Study [see comments]
1990
Using Single-Agent Therapy in Adult Patients with Advanced Soft Tissue Sarcoma Can Still Be Considered Standard Care
2005
The importance of dose intensity in chemotherapy of metastatic breast cancer.
1984 Standout
The role of radiotherapy in cancer treatment
2005 Standout
Multimodality Therapy for Limited-Stage Small-Cell Lung Cancer
2016
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Cancer treatment and survivorship statistics, 2016
2016 Standout
Proposal for classifying the acute emetogenicity of cancer chemotherapy.
1997 Standout
Therapy of small cell lung cancer: a perspective on two decades of clinical research.
1988
Cancer treatment and survivorship statistics, 2019
2019 Standout
The biology and treatment of acute lymphoblastic leukemia in adults
1995
The treatment of soft tissue sarcomas with focus on chemotherapy: A review
1986
Canadian multicenter randomized trial comparing sequential and alternating administration of two non-cross-resistant chemotherapy combinations in patients with limited small-cell carcinoma of the lung.
1987
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Monoclonal antibody-purged autologous bone marrow transplantation therapy for multiple myeloma
1991
Multiple Myeloma
2011 Standout
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
1999 Standout
Prognostic value of pretreatment serum beta 2 microglobulin in myeloma: a Southwest Oncology Group Study [see comments]
1990
Reduction of Doxorubicin Cardiotoxicity by Prolonged Continuous Intravenous Infusion
1982
International Staging System for Multiple Myeloma
2005 Standout
Preclinical studies identifying carboplatin as a viable cisplatin alternative
1985
Multimodal therapy for limited small-cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders: a Southwest Oncology Group Study.
1987
Works of S E Rivkin being referenced
Palliation in malignant pleural effusion.
1975
Multicenter clinical trial of mitoxantrone in non-Hodgkin's lymphoma and Hodgkin's disease.
1991
Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas.
1980
Improved survival duration with combination chemotherapy induction for multiple myeloma: a Southwest Oncology Group Study.
1986
Phase II evaluation of maytansine in refractory non-Hodgkin's lymphoma: a Southwest Oncology Group study.
1982
Small-Cell Carcinoma of the Lung: Combined Chemotherapy and Radiation
1978
Combined therapies for squamous-cell carcinoma of the esophagus, a Southwest Oncology Group Study (SWOG-8037).
1987
Vinblastine, bleomycin, and cis-dichlorodiammineplatinum(II) in disseminated testicular cancer: preliminary report of a Southwest Oncology Group Study.
1980
Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation, and maintenance chemotherapy
1989
Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcomas: a randomized comparative trial. A phase III, Southwest Oncology Group Study (7613).
1987
Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation, and maintenance chemotherapy
1989